Biomedicinals from the phytosymbionts of marine invertebrates: A molecular approach

被引:63
作者
Dunlap, Walter C.
Battershill, Christopher N.
Liptrot, Catherine H.
Cobb, Rosemary E.
Bourne, David G.
Jaspars, Marcel
Long, Paul F.
Newman, David J.
机构
[1] Australian Inst Marine Sci, Townsville, Qld 4810, Australia
[2] Univ Aberdeen, Dept Chem, Aberdeen, Scotland
[3] Univ London, Sch Pharm, London WC1N 1AX, England
[4] NCI, Nat Prod Branch, Dev Therapeut Program, Frederick, MD 21701 USA
基金
英国生物技术与生命科学研究理事会; 美国国家卫生研究院;
关键词
biomedicinals; marine natural products; symbionts; cyanobacteria; sponges; polyketides; nonribosomal peptides; heterologous expression;
D O I
10.1016/j.ymeth.2007.03.001
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Marine invertebrate animals such as sponges, gorgonians, tunicates and bryozoans are sources of biomedicinally relevant natural products, a small but growing number of which are advancing through clinical trials. Most metazoan and anthozoan species harbour commensal microorganisms that include prokaryotic bacteria, cyanobacteria (blue-green algae), eukaryotic microalgae, and fungi within host tissues where they reside as extra- and intra-cellular symbionts. In some sponges these associated microbes may constitute as much as 40% of the holobiont volume. There is now abundant evidence to suggest that a significant portion of the bioactive metabolites thought originally to be products of the source animal are often synthesized by their symbiotic microbiota. Several anti-cancer metabolites from marine sponges that have progressed to pre-clinical or clinical-trial phases, such as discodermolide, halichondrin B and bryostatin 1, are thought to be products derived from their microbiotic consortia. Freshwater and marine cyanobacteria are well recognised for producing numerous and structurally diverse bioactive and cytotoxic secondary metabolites suited to drug discovery. Sea sponges often contain dominant taxa-specific populations of cyanobacteria, and it is these phytosymbionts (= photosymbionts) that are considered to be the true biogenic source of a number of pharmacologically active polyketides and nonribosomally synthesized peptides produced within the sponge. Accordingly, new collections can be pre-screened in the field for the presence of phytobionts and, together with metagenomic screening using degenerate PCR primers to identify key polyketide synthase (PKS) and nonribosomal peptide synthetase (NRPS) genes, afford a biodiscovery rationale based on the therapeutic prospects of phytochemical selection. Additionally, new cloning and biosynthetic expression strategies may provide a sustainable method for the supply of new pharmaceuticals derived from the uncultured phytosymbionts of marine organisms. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:358 / 376
页数:19
相关论文
共 159 条
[1]   Tenuecyclamides A-D, cyclic hexapeptides from the cyanobacterium Nostoc spongiaeforme var. tenue [J].
Banker, R ;
Carmeli, S .
JOURNAL OF NATURAL PRODUCTS, 1998, 61 (10) :1248-1251
[2]   To BAC or not to BAC:: marine ecogenomics [J].
Béjà, O .
CURRENT OPINION IN BIOTECHNOLOGY, 2004, 15 (03) :187-190
[3]   THE ISOLATION OF A NEW THYMINE PENTOSIDE FROM SPONGES [J].
BERGMANN, W ;
FEENEY, RJ .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1950, 72 (06) :2809-2810
[4]   CONTRIBUTIONS TO THE STUDY OF MARINE PRODUCTS .32. THE NUCLEOSIDES OF SPONGES .1. [J].
BERGMANN, W ;
FEENEY, RJ .
JOURNAL OF ORGANIC CHEMISTRY, 1951, 16 (06) :981-987
[5]   CONTRIBUTIONS TO THE STUDY OF MARINE PRODUCTS .39. THE NUCLEOSIDES OF SPONGES .3. SPONGOTHYMIDINE AND SPONGOURIDINE [J].
BERGMANN, W ;
BURKE, DC .
JOURNAL OF ORGANIC CHEMISTRY, 1955, 20 (11) :1501-1507
[6]   Novel marine and microbial natural product inhibitors of vacuolar ATPase [J].
Beutler, JA ;
McKee, TC .
CURRENT MEDICINAL CHEMISTRY, 2003, 10 (09) :787-796
[7]  
Bewley CA, 1998, ANGEW CHEM INT EDIT, V37, P2163, DOI 10.1002/(SICI)1521-3773(19980904)37:16<2162::AID-ANIE2162>3.0.CO
[8]  
2-2
[9]   Identification of a new chondropsin class of antitumor compound that selectively inhibits V-ATPases [J].
Bowman, EJ ;
Gustafson, KR ;
Bowman, BJ ;
Boyd, MR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (45) :44147-44152
[10]   Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: Potential applications to microbicide development [J].
Boyd, MR ;
Gustafson, KR ;
McMahon, JB ;
Shoemaker, RH ;
OKeefe, BR ;
Mori, T ;
Gulakowski, RJ ;
Wu, L ;
Rivera, MI ;
Laurencot, CM ;
Currens, MJ ;
Cardellina, JH ;
Buckheit, RW ;
Nara, PL ;
Pannell, LK ;
Sowder, RC ;
Henderson, LE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (07) :1521-1530